Results 101 to 110 of about 19,830 (241)
Aim To explore how patients experience their fundamental care needs during the early phase of recovery after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. Design Qualitative with deductive approach. Methods Thirteen participants were interviewed approximately 2 weeks after surgery.
Pernilla Bangsparr +2 more
wiley +1 more source
Pseudomyxoma peritonei (PMP) - a rare entity [PDF]
Pseudomyxoma peritonei (PMP) is a rare complication of mucinous tumours of appendiceal or ovarian origin that results in peritoneal and omental implants.
Farzanah Ismail +5 more
core +2 more sources
Malignant bowel obstruction (MBO) is a highly morbid complication of abdominal malignancies and careful patient selection is critical to identify patients likely to benefit from operative management. Hypoalbuminaemia and peritoneal disease were associated with inferior survival and high rates of readmission.
Harriet O'Rourke +9 more
wiley +1 more source
Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei [PDF]
Pseudomyxoma peritonei is a fatal clinical syndrome with mucinous tumor cells disseminated into peritoneal cavity and secreting abundant mucinous ascites. The serum tumor markers CEA, CA19-9, and CA125 are used to monitor pseudomyxoma peritonei remission,
Järvinen, Petrus +6 more
core +1 more source
Background Mucoceles resulting from cystadenomas of the appendix are uncommon. Although rare, rupture of the mucoceles can occur with or without causing any abdominal complaint.
Hwang Yome-Shine +5 more
doaj +1 more source
Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers
ABSTRACT Peritoneal malignancy often indicates disruptions in multiple physiological systems resulting from widespread cancer. The heterogenous origin and dynamic nature of peritoneal cancer make it difficult to treat with standard approaches that fit into guidelines.
Ada I. Ozcan +4 more
wiley +1 more source
Pseudomyxoma peritonei in a young male [PDF]
Pseudomyxoma peritonei (PMP) is an uncommon surgical entity, characterized by diffuse deposition of mucin within the peritoneal cavity secondary to mucinous tumors of the ovary or appendix.
Satyanarayana Gorthi +3 more
core +1 more source
Journal of Hospital Medicine, Volume 21, Issue 1, Page 118-119, January 2026.
Miguel Buendia +2 more
wiley +1 more source
Abstract Aim Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is the standard treatment for peritoneal metastases (PM) of colorectal or appendiceal origin. Rectal anastomotic leakage (RAL) or rectal stump blow‐out is a serious complication following rectal resection after CRS‐HIPEC. This study aimed to compare outcomes
Lana Ghanipour +4 more
wiley +1 more source
ABSTRACT Although rare, appendiceal cancer can metastasize to unusual sites, including the inguinal canal. In patients with a history of abdominal malignancy presenting with an inguinal hernia, metastatic disease should be considered for adequate recognition and early oncologic intervention.
Peter Mounas +3 more
wiley +1 more source

